IDP is accredited by the Standards Council of Canada for performing safety pharmacology studies in rodents.

IDP provides SOP-driven cGLP safety pharmacology studies in mice and rat models. These services fulfill the requirements for IND and/or CTA filing for rodent toxicology. We offer customized services, which include single dose range finding or acute toxicity , repeat dose, or acute , chronic or subchronic toxicity studies. These services include comprehensive CBC/differential and blood chemistry screen results with specialized analytical panels available and complete histopathology and pathology report. IDP may also perform bioequivalence of generic studies in rodents for Health Canada /FDA submission.

  • Rat or mouse-based studies supporting IND or CTA submissions
  • Multiple (acute, chronic, subchronic) dosing regimens and varying methods of administration
  • Maximum tolerated dose (MTD)
  • Subchronic toxicity
  • Single dose range-finding and acute toxicity studies
  • Repeated dose
  • Compliant to OECD, Health Canada and FDA requirements
  • Includes comprehensive CBC/differential and blood chemistry analysis
  • Histopathological assessment by board-certified veterinary pathologist
  • Full Quality Management system support

Please contact Dr. Nancy Dos Santos to discuss your cGLP preclinical development needs. 

Dr. Nancy Dos Santos , PhD, MBA

Director, Investigational Drug Program
Back to top